1 Overall survival |
2 |
624 |
Hazard Ratio (Random, 95% CI) |
0.83 [0.53, 1.31] |
2 Overall survival ‐ HER2 status |
2 |
|
Hazard Ratio (Random, 95% CI) |
Subtotals only |
2.1 HER2‐positive |
2 |
192 |
Hazard Ratio (Random, 95% CI) |
0.85 [0.48, 1.50] |
2.2 HER2‐negative |
2 |
421 |
Hazard Ratio (Random, 95% CI) |
0.84 [0.50, 1.40] |
3 Overall survival ‐ ER status |
2 |
|
Hazard Ratio (Random, 95% CI) |
Subtotals only |
3.1 ER‐positive |
2 |
426 |
Hazard Ratio (Random, 95% CI) |
0.83 [0.48, 1.42] |
3.2 ER‐negative |
2 |
200 |
Hazard Ratio (Random, 95% CI) |
1.04 [0.70, 1.55] |
4 Overall survival ‐ only bone metastasis |
2 |
226 |
Hazard Ratio (Random, 95% CI) |
0.91 [0.49, 1.69] |
5 Progression‐free survival |
2 |
|
Hazard Ratio (Random, 95% CI) |
Subtotals only |
5.1 Local progression‐free survival |
2 |
|
Hazard Ratio (Random, 95% CI) |
0.22 [0.08, 0.57] |
5.2 Distant progression‐free survival |
1 |
|
Hazard Ratio (Random, 95% CI) |
1.42 [1.08, 1.86] |